Published in J Clin Lab Immunol on May 01, 1981
Suppression of T-lymphocyte responses to Entamoeba histolytica antigen by immune sera. Infect Immun (1990) 0.90
An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet (1995) 13.84
The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr (1967) 10.30
Proposed diagnostic criteria for neurocysticercosis. Neurology (2001) 9.15
Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol (1998) 7.84
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61
Individual Antigenic Specificity of Isolated Antibodies. Science (1963) 7.27
Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am J Hum Genet (1988) 7.00
Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science (1995) 6.84
Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science (1972) 6.80
Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis (2000) 6.71
Correlation between subjective and objective evaluation of the nasal airway. A systematic review of the highest level of evidence. Clin Otolaryngol (2009) 5.33
RECONSTITUTION OF ACTIVE TOBACCO MOSAIC VIRUS FROM ITS INACTIVE PROTEIN AND NUCLEIC ACID COMPONENTS. Proc Natl Acad Sci U S A (1955) 5.25
Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol (2000) 5.01
Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet (1975) 4.85
Native American mitochondrial DNA analysis indicates that the Amerind and the Nadene populations were founded by two independent migrations. Genetics (1992) 4.78
Cyclospora species--a new protozoan pathogen of humans. N Engl J Med (1993) 4.56
Differences in anti-protein A activity among IgG subgroups. J Immunol (1969) 4.56
A neural basis for general intelligence. Science (2000) 4.49
The mediator of cellular immunity. II. Migration of immunologically committed lymphocytes into inflammatory exudates. J Exp Med (1971) 4.13
The mediator of cellular immunity. I. The life-span and circulation dynamics of the immunologically committed lymphocyte. J Exp Med (1971) 4.00
Phylogenetic insight into evolution of mammalian Fc fragment of gamma G globulin using staphylococcal protein A. J Immunol (1970) 3.84
X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med (1975) 3.70
Microtubules from mammalian brain: some properties of their depolymerization products and a proposed mechanism of assembly and disassembly. Proc Natl Acad Sci U S A (1974) 3.59
Community infection ratio as an indicator for tuberculosis control. Lancet (1995) 3.53
Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol (2000) 3.39
Preparation of tubulin from brain. Methods Enzymol (1982) 3.39
Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med (1977) 3.38
Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med (1975) 3.36
Opsonic, agglutinating, and complement-fixing antibodies in patients with subacute bacterial endocarditis. J Lab Clin Med (1968) 3.20
Effect of El Niño and ambient temperature on hospital admissions for diarrhoeal diseases in Peruvian children. Lancet (2000) 3.11
Diagnostic value of the Widal test in areas endemic for typhoid fever. Am J Trop Med Hyg (1978) 3.06
ELECTRON SHADOW MICROGRAPHY OF THE TOBACCO MOSAIC VIRUS PROTEIN. Science (1945) 3.00
Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med (1976) 2.98
The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients. Bull World Health Organ (1968) 2.96
Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med (1978) 2.95
Studies of T- and B-lymphocytes in patients with connective tissue diseases. J Clin Invest (1973) 2.84
Suppression of leukocyte chemotaxis by human IgA myeloma components. J Exp Med (1976) 2.77
Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae. Bull World Health Organ (1969) 2.77
Inhibition of streptococcal attachment to receptors on human buccal epithelial cells by antigenically similar salivary glycoproteins. Infect Immun (1975) 2.76
Cyanobacterial phycobilisomes. Characterization of the phycobilisomes of Synechococcus sp. 6301. J Biol Chem (1978) 2.73
Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan. Bull World Health Organ (1968) 2.71
Separation and characterization of microtubule proteins from calf brain. Biochemistry (1977) 2.71
Site-specific DNA condensation and pairing mediated by the int protein of bacteriophage lambda. Proc Natl Acad Sci U S A (1982) 2.67
Use of polylysine for adsorption of nuclei acids and enzymes to electron microscope specimen films. Proc Natl Acad Sci U S A (1977) 2.67
Diarrhoeal mortality in two Bangladeshi villages with and without community-based oral rehydration therapy. Lancet (1979) 2.66
Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology (1997) 2.60
Antiphagocytic effects of staphylococcal protein A. J Immunol (1969) 2.59
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis (1977) 2.57
Calcific neurocysticercosis and epileptogenesis. Neurology (2004) 2.57
OMFS: Gender imbalance? Br Dent J (2016) 2.56
Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol Rev (1977) 2.50
Pathologic findings in mesangiopathic glomerulonephritis in Navajo Indians. Arch Pathol Lab Med (1989) 2.48
B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens. J Exp Med (1977) 2.44
Treatment of neurocysticercosis: current status and future research needs. Neurology (2006) 2.41
Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus. Arthritis Rheum (1973) 2.40
Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J Exp Med (1982) 2.39
Protein A reactivity with mouse immunoglobulins. Structural relationship between some mouse and human immunoglobulins. J Immunol (1970) 2.38
The mediator of cellular immunity. IV. Cooperation between lymphocytes and mononuclear phagocytes. Cell Immunol (1971) 2.34
Electron microscopy of tobacco mosaic virus under conditions of minimal beam exposure. J Mol Biol (1970) 2.32
Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet (1987) 2.32
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol (1986) 2.31
Mode of DNA packing within bacteriophage heads. J Mol Biol (1973) 2.29
A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer (2000) 2.27
Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6. Aliment Pharmacol Ther (2013) 2.26
Molecular assays for surveillance of antifolate-resistant malaria. Lancet (1998) 2.26
Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection. Aliment Pharmacol Ther (2014) 2.22
Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest (1973) 2.19
Quantitation of staphylococcal protein A: Determination of equilibrium constant and number of protein A residues on bacteria. J Immunol (1970) 2.19
Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol (1998) 2.17
The mediator of cellular immunity. 3. Lymphocyte traffic from the blood into the inflamed peritoneal cavity. J Exp Med (1971) 2.17
An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal. J Infect Dis (1975) 2.15
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut (2011) 2.14
Opsonic activity of agammaglobulinemic human sera. J Immunol (1971) 2.13
GM allotypes in Native Americans: evidence for three distinct migrations across the Bering land bridge. Am J Phys Anthropol (1985) 2.11
The mechanism of microtubule assembly in vitro. J Supramol Struct (1974) 2.10
Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh. Bull World Health Organ (1981) 2.06
The effect of magnesium sulphate infusion on the incidence and severity of emergence agitation in children undergoing adenotonsillectomy using sevoflurane anaesthesia. Anaesthesia (2013) 2.06
A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr (1999) 2.05
Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology (2005) 2.04
High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis (1999) 2.02
Relationship between enterotoxin production and serotype in enterotoxigenic Escherichia coli. Infect Immun (1979) 2.01
Periodontal disease at the biofilm-gingival interface. J Periodontol (2007) 2.01
Rheumatoid factors in subacute bacterial endocarditis--bacterium, duration of disease or genetic predisposition? Ann Intern Med (1968) 2.00
Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol (1995) 2.00
T and B lymphocytes in acute and chronic hepatitis. Clin Immunol Immunopathol (1974) 1.98
Peripheral blood T and B cells in chronic inflammatory bowel disease. Gastroenterology (1974) 1.97
Helicobacter pylori in the drinking water in Peru. Gastroenterology (1996) 1.95
Microtubules grow and shorten at intrinsically variable rates. J Biol Chem (1992) 1.92
Molecular architecture of a light-harvesting antenna. In vitro assembly of the rod substructures of Synechococcus 6301 phycobilisomes. J Biol Chem (1981) 1.92
Estimating the true extent of cognitive decline in the old old. J Am Geriatr Soc (1999) 1.90
Fecal contamination of shanty town toddlers in households with non-corralled poultry, Lima, Peru. Am J Public Health (1990) 1.89
Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg (1990) 1.88
Diabetes mellitus in the Pima Indians: genetic and evolutionary considerations. Am J Phys Anthropol (1983) 1.88
Opsonic activity in human serum deficient in C2. J Immunol (1972) 1.88